Universe Pharmaceuticals ... (UPC)
0.51
0.01 (1.74%)
At close: Jan 28, 2025, 2:00 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | 32.31M | 40.14M | 47.98M | 30.70M | 33.23M | 28.51M |
| Cost of Revenue | 21.99M | 18.25M | 22.66M | 16.61M | 19.82M | 15.11M |
| Gross Profit | 10.32M | 21.89M | 25.33M | 14.09M | 13.41M | 13.41M |
| Operating Income | -3.53M | -7.02M | 13.59M | 10.25M | 9.75M | 9.66M |
| Interest Income | n/a | n/a | 239.55K | n/a | n/a | n/a |
| Pretax Income | -3.85M | -7.98M | 13.68M | 10.10M | 9.65M | 9.52M |
| Net Income | -6.16M | -8.74M | 11.32M | 7.56M | 7.55M | 7.60M |
| Selling & General & Admin | 9.00M | 20.84M | 6.27M | 2.80M | 2.29M | 2.39M |
| Research & Development | 4.86M | 7.64M | 5.47M | 583.13K | 618.44K | 789.38K |
| Other Expenses | -17.53K | 430.31K | -80.43K | 365.77K | 445.77K | 5.01K |
| Operating Expenses | 13.84M | 28.91M | 11.74M | 3.74M | 3.36M | 3.65M |
| Interest Expense | 156.79K | 162.40K | 101.60K | 123.76K | 129.27K | 164.92K |
| Selling & Marketing Expenses | 6.78M | 19.08M | 2.97M | 1.56M | 1.58M | 1.68M |
| Cost & Expenses | 35.84M | 47.16M | 34.39M | 20.35M | 23.18M | 18.75M |
| Income Tax | 2.31M | 752.42K | 2.36M | 2.54M | 2.10M | 1.92M |
| Shares Outstanding (Basic) | 3.63M | 3.63M | 3.63M | 3.67M | 3.67M | 21.00M |
| Shares Outstanding (Diluted) | 3.63M | 3.63M | 3.63M | 3.67M | 3.67M | 21.00M |
| EPS (Basic) | -1.7 | -2.41 | 3.12 | 2.06 | 2.05 | 0.36 |
| EPS (Diluted) | -1.7 | -2.41 | 3.12 | 2.06 | 2.05 | 0.36 |
| EBITDA | -3.22M | -7.33M | 14.20M | 10.61M | 10.17M | 10.11M |
| Depreciation & Amortization | 508.79K | 533.95K | 446.88K | 410.08K | 418.43K | 452.73K |